Sign Up to like & get recommendations! 0
Published in 2017 at "Acta Diabetologica"
DOI: 10.1007/s00592-017-1021-y
Abstract: AbstractAimsOur aim was to detect the frequency of glucokinase (GCK) gene mutations in a cohort of patients with impaired fasting glucose and to describe the clinical manifestations of identified variants. We also aimed at predicting… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Diabetes research and clinical practice"
DOI: 10.1016/j.diabres.2021.108799
Abstract: AIMS The status of metabolic abnormalities including impaired fasting glucose (IFG) can change over time, yet little is known about how exposure duration to IFG is related to diabetes risk. METHODS Using nationally representative data… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2018.07.013
Abstract: OBJECTIVES Early stages of diabetes are associated with an increased glomerular filtration rate (GFR). Little is known, however, about the change in GFR among patients with impaired fasting glucose (IFG). We aimed to evaluate the… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Nature Reviews Endocrinology"
DOI: 10.1038/s41574-019-0316-1
Abstract: The prevention of type 2 diabetes mellitus (T2DM) is a target priority for the WHO and the United Nations and is a key priority in the 2018 Berlin Declaration, which is a global call for… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-06252-6
Abstract: The gut-derived hormone Fibroblast growth factor 19 (FGF19) could regulate glucose metabolism and is induced by bile acids (BAs) through activating Farnesoid X Receptor (FXR). FGF19 was found to decrease in subjects with isolated-impaired fasting… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Hypertension"
DOI: 10.1097/01.hjh.0000837348.04843.5b
Abstract: Objective: Impaired fasting glucose (IFG) predisposes to future development of type 2 diabetes mellitus (T2DM) and may also be associated with increased cardiovascular disease (CVD) risk. Hypertension is an established CVD risk factor. The aim… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "BMJ Open"
DOI: 10.1136/bmjopen-2019-029628
Abstract: Objective This study estimated the burden and characterised the risk factors associated with diabetes and impaired fasting glucose (IFG) in an undiagnosed rural population. Design Data for 36 960 participants from the Henan Rural Cohort baseline… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Pakistan Journal of Medical Sciences"
DOI: 10.12669/pjms.36.3.57
Abstract: Objectives: To determine the frequency of impaired fasting glucose in first degree relatives of people with Type-II diabetes and its association with BMI. Methods: This cross-sectional study was conducted in Diabetic clinic of Shaikh Zayed… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Diabetes"
DOI: 10.2337/db20-1612-p
Abstract: Prediabetes is a key risk for type 2 diabetes and its remission to normal glucose regulation has been shown to prevent or delay the onset of diabetes. However, which factors play roles in remission is… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2020.00525
Abstract: Background: Diabetes correlates with poor prognosis in patients with COVID-19, but very few studies have evaluated whether impaired fasting glucose (IFG) is also a risk factor for the poor outcomes of patients with COVID-19. Here… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.1013162
Abstract: Objective This epidemiological study (1) identified factors associated with impaired fasting glucose using 3,019 subjects (≥30 years old and read more here.